UiPath CEO Dines $33M Exit as Insiders Shun Stock
CEO Daniel Dines sold $33.07M in UiPath shares in mid-October near current trading prices, capping 90 days of $38.26M total insider selling with zero insider purchases across the executive team. The q
UiPath CEO Sells $33M as Stock Hovers Near Sale Price
NEW YORK, October 23 —
When Daniel Dines sold 2.5 million UiPath, Inc. (PATH) shares for $33.07 million on October 15-16, he did so at prices PATH has barely cleared since, a founder exit that lands squarely on the question of whether $13-14 is a floor or a ceiling.
- CEO Dines sold 2.5M shares at $12.98, $13.83 over two days; PATH trades at $14.13 today.
- 90-day insider selling totals $38.26M with zero purchases; short interest sits at 26.8% of float.
- TTM free cash flow: $474M; net cash: $1.2B; forward earnings multiple: 15.3x.
Grant, Then Sell
Dines' two-day disposal is the peak of a 90-day executive retreat, not an isolated transaction. CPO/CTO Raghavendra Malpani sold three times between September 16 and October 9 for $2.33 million; COO Ashim Gupta cleared $2.5 million across two open-market sales; CLO Brad Brubaker added $374,000 on October 12. The pattern carries an ironic footnote: on September 3, the same day UiPath filed its earnings 8-K, the company granted RSU awards of 1.125 million shares each to Malpani and Gupta and 300,000 to Brubaker. They received fresh equity September 3, then sold existing holdings throughout the following weeks: $38.26 million out, zero in.
Cheap on Paper, Contested in Practice
UiPath has beaten EPS estimates in three of the past four quarters while expanding its automation platform: RPA, AI agent orchestration via Maestro, intelligent extraction, and test automation across financial services, healthcare, and manufacturing. An 82.6% gross margin business with $1.72 billion in trailing revenue growing 13.4%, $474 million in free cash flow, and $1.2 billion in net cash trades at 15.3x forward earnings, a multiple that looks compressed for the profile. Against that, 26.8% short interest in PATH reflects a substantial market bet that growth slows from here, a position the DCF calculator can help test against PATH's free cash flow.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| PATH | $7.4B | 15.3x | -15.4% |
| AI | $2.0B | n/a | -32.6% |
| U | $18.0B | 23.4x | +8.0% |
| UPST | $2.3B | 6.7x | -54.7% |
| SOUN | $2.0B | n/a | -75.0% |
| SNOW | $114.8B | 107.7x | +21.7% |
What the Earnings Print Decides
PATH trades at $14.13, within $1 of Dines' mid-October exit prices. An analyst consensus target of $15.32 implies roughly 8% upside, a spread that frames the question without settling it. The next earnings report is the operative checkpoint: if revenue growth holds above 13% and forward guidance expands, the forward multiple looks like real value; if growth slows, the founder's timing looks prescient. For now, substantial short interest and zero insider purchases across the full executive team show a stock the people closest to it chose not to buy at these prices. Run the free UiPath, Inc. deep-dive →
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
How much stock did UiPath CEO Daniel Dines sell?
CEO Daniel Dines sold 2.5 million UiPath shares on October 15-16 for $33.07 million, at prices between $12.98 and $13.83. The stock has traded near those same prices since the sale, currently hovering around $14.13.
What does the insider selling pattern suggest?
Over 90 days, UiPath executives sold $38.26M total with zero insider purchases. The executives received RSU grants on September 3, then sold existing shares in subsequent weeks, signaling skepticism about valuation at current prices across the entire leadership team.
What's UiPath's forward valuation multiple?
UiPath trades at 15.3x forward earnings despite an 82.6% gross margin, $1.72B TTM revenue growing 13.4%, and $1.2B net cash. The multiple appears compressed for the profile, yet 26.8% short interest reflects substantial market skepticism about whether growth will decelerate.
What's the next catalyst for UiPath stock?
The upcoming earnings report is the operative checkpoint. If revenue growth holds above 13% and forward guidance expands, the current valuation looks like genuine value; if growth slows, CEO Dines' exit timing appears prescient.
UiPath CEO and Chairman Daniel Dines sold $33.07 million in stock over two days in mid-October at prices from $12.98 to $13.83 per share — just below the $14.13 level where PATH trades today. The exit comes as UiPath generates $474 million in annual free cash flow on a near-debt-free balance sheet, leaving investors to decide whether the founder sees the current price as a ceiling or a floor.